EE9900487A - 5-arüül-3-(8-asabitsüklo[3.2.1]okt-3-üül)-1,3,4-oksadiasool-2(3H)-ooni derivaadid kui 5-HT4 retseptori ligandid - Google Patents

5-arüül-3-(8-asabitsüklo[3.2.1]okt-3-üül)-1,3,4-oksadiasool-2(3H)-ooni derivaadid kui 5-HT4 retseptori ligandid

Info

Publication number
EE9900487A
EE9900487A EEP199900487A EEP9900487A EE9900487A EE 9900487 A EE9900487 A EE 9900487A EE P199900487 A EEP199900487 A EE P199900487A EE P9900487 A EEP9900487 A EE P9900487A EE 9900487 A EE9900487 A EE 9900487A
Authority
EE
Estonia
Prior art keywords
oxadiazol
azabicyclo
oct
aryl
derivatives
Prior art date
Application number
EEP199900487A
Other languages
English (en)
Inventor
Jegham Samir
Lochead Alistair
Galli Fr�d�ric
Nedelec Alain
Samson Axelle
Gallet Thierry
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE9900487A publication Critical patent/EE9900487A/et
Publication of EE03769B1 publication Critical patent/EE03769B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP199900487A 1997-04-18 1998-04-15 5-arüül-3-(8-asabitsüklo[3.2.1]okt-3-üül)-1,3,4-oksadiasool-2(3H)-ooni derivaadid kui 5-HT4 retseptori ligandid EE03769B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704802A FR2762316B1 (fr) 1997-04-18 1997-04-18 Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
PCT/FR1998/000754 WO1998047898A1 (fr) 1997-04-18 1998-04-15 Derives de 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one en tant que ligands des recepteurs 5-ht4

Publications (2)

Publication Number Publication Date
EE9900487A true EE9900487A (et) 2000-06-15
EE03769B1 EE03769B1 (et) 2002-06-17

Family

ID=9506076

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900487A EE03769B1 (et) 1997-04-18 1998-04-15 5-arüül-3-(8-asabitsüklo[3.2.1]okt-3-üül)-1,3,4-oksadiasool-2(3H)-ooni derivaadid kui 5-HT4 retseptori ligandid

Country Status (32)

Country Link
US (1) US6255319B1 (et)
EP (1) EP0975631B1 (et)
JP (1) JP2001521542A (et)
KR (1) KR20010006452A (et)
CN (1) CN1260794A (et)
AR (1) AR012458A1 (et)
AT (1) ATE206424T1 (et)
AU (1) AU742666B2 (et)
BG (1) BG64053B1 (et)
BR (1) BR9808926A (et)
CA (1) CA2286106A1 (et)
CO (1) CO4750656A1 (et)
CZ (1) CZ289154B6 (et)
DE (1) DE69801905T2 (et)
DK (1) DK0975631T3 (et)
EE (1) EE03769B1 (et)
ES (1) ES2165162T3 (et)
FR (1) FR2762316B1 (et)
HU (1) HUP0002456A3 (et)
IL (1) IL132352A0 (et)
NO (1) NO995040L (et)
NZ (1) NZ500396A (et)
PL (1) PL186894B1 (et)
PT (1) PT975631E (et)
RU (1) RU2186066C2 (et)
SI (1) SI0975631T1 (et)
SK (1) SK283441B6 (et)
TR (1) TR199902600T2 (et)
TW (1) TW502005B (et)
UA (1) UA57071C2 (et)
WO (1) WO1998047898A1 (et)
ZA (1) ZA983257B (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
AU2004226452B2 (en) * 2003-03-26 2008-07-24 Merck Sharp & Dohme Corp. Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
CA2545513C (en) * 2003-11-18 2013-01-08 Boehringer Ingelheim International Gmbh Solid pharmaceutical preparation form
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
EA200801608A1 (ru) 2004-06-15 2008-10-30 Пфайзер Инк. Производные бензимидазолонкарбоновой кислоты
SE532388C2 (sv) * 2008-03-14 2010-01-12 Tetra Laval Holdings & Finance Förpackningslaminat och -behållare med två separata gasbarriärskikt samt metod för deras framställning
CN105163586B (zh) * 2013-03-15 2018-08-28 孟山都技术公司 用于控制线虫害虫的n-、c-二取代的唑类
GB201814151D0 (en) * 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2118812C (en) * 1991-09-12 2006-01-17 Francis David King 5-ht4 receptor antagonists
ES2118842T3 (es) * 1992-02-04 1998-10-01 Eisai Co Ltd Derivados del acido aminobenzoico.
EP0625149A1 (en) * 1992-02-06 1994-11-23 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
CA2236357C (en) * 1995-11-09 2006-10-17 Synthelabo 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht4 or h3 receptor ligands

Also Published As

Publication number Publication date
CZ364199A3 (cs) 2000-03-15
BG64053B1 (bg) 2003-11-28
CA2286106A1 (en) 1998-10-29
ZA983257B (en) 1998-10-19
RU2186066C2 (ru) 2002-07-27
IL132352A0 (en) 2001-03-19
JP2001521542A (ja) 2001-11-06
CZ289154B6 (cs) 2001-11-14
PT975631E (pt) 2002-03-28
WO1998047898A1 (fr) 1998-10-29
US6255319B1 (en) 2001-07-03
ATE206424T1 (de) 2001-10-15
HUP0002456A2 (hu) 2000-12-28
SK283441B6 (sk) 2003-07-01
PL336315A1 (en) 2000-06-19
AU742666B2 (en) 2002-01-10
TW502005B (en) 2002-09-11
FR2762316B1 (fr) 1999-12-17
ES2165162T3 (es) 2002-03-01
DE69801905D1 (de) 2001-11-08
SI0975631T1 (en) 2002-06-30
DE69801905T2 (de) 2002-07-04
TR199902600T2 (xx) 2000-03-21
DK0975631T3 (da) 2002-01-28
FR2762316A1 (fr) 1998-10-23
BG103810A (en) 2000-06-30
NZ500396A (en) 2001-04-27
CN1260794A (zh) 2000-07-19
UA57071C2 (uk) 2003-06-16
KR20010006452A (ko) 2001-01-26
EE03769B1 (et) 2002-06-17
HUP0002456A3 (en) 2001-03-28
CO4750656A1 (es) 1999-03-31
EP0975631B1 (fr) 2001-10-04
BR9808926A (pt) 2000-08-01
EP0975631A1 (fr) 2000-02-02
AU7341598A (en) 1998-11-13
NO995040L (no) 1999-12-16
AR012458A1 (es) 2000-10-18
PL186894B1 (pl) 2004-03-31
NO995040D0 (no) 1999-10-15
SK142699A3 (en) 2000-05-16

Similar Documents

Publication Publication Date Title
IL124364A0 (en) 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2 (3h)-one derivatives for use as 5-ht4 or h3 receptor ligands
HK1024469A1 (en) Quinoline derivatives as tachykinin nk3 receptor antagonists.
IL141506A0 (en) 4,4-biarylpiperidine derivatives with opioid receptor activity
EP0470350A3 (en) Multi-spindle machine for drilling, milling or similar works
HUP9802433A3 (en) 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use
EE9900487A (et) 5-arüül-3-(8-asabitsüklo[3.2.1]okt-3-üül)-1,3,4-oksadiasool-2(3H)-ooni derivaadid kui 5-HT4 retseptori ligandid
ZA971513B (en) Oxa-and thia-diazole muscarinic receptor antagonists
TR199901381A3 (tr) Diaza-spiro[3,5]nonan türevleri.
EP0681583A1 (en) TRICYCLIC HETEROCYCLIC COMPOUNDS AS 5-HT4 RECEPTOR ANTAGONISTS.
GB9704376D0 (en) Tetrahydropyridine derivatives as dopamine receptor subtype ligands
IL142362A0 (en) Ureidopiperidine derivatives as selective human nk3 receptor antagonists
GB9703382D0 (en) Tetrahydropyridine derivatives as dopamine receptor subtype ligands
DK1133494T3 (da) 8-Azabicyclo[3.2.1]oct-2-en-derivater
FR2763067B1 (fr) Derives de 3-(1-azabicyclo[2.2.2] oct-3-ylalkyl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
AU1449997A (en) Diazabicyclo-octane derivatives as 5-ht receptor ligands
ZA983776B (en) 3-(pyrrolidin-3-yl)-1, 3, 4-oxadiazol-2(3h)-one derivatives their preparation and their therapeutic application
TW334917U (en) Adjustable multi-spindle drills seat
ZA984639B (en) 8-Azabicyclo [3.2.1]oct-2-ene and octane derivatives their preparation and use

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

MM4A Lapsed by not paying the annual fees

Effective date: 20040415